New tissue-engineered platform for islet cell transplantation found effective in type 1 diabetic patients

Researchers from the Diabetes Research Institute (DRI) have produced the clinical results demonstrating that pancreatic islet cells transplanted within a tissue-engineered platform can achieve insulin independence in type 1 diabetes. The research findings are published in the New England Journal of Medicine. Fluorescence microscopy of islets in the omentum transplanted within the biologic scaffold. In …

New tissue-engineered platform for islet cell transplantation found effective in type 1 diabetic patients Read More »